ArticleACS pharmacology & translational science2024

Structure-Based Optimization of Pyrazinamide-Containing Macrocyclic Derivatives as Fms-like Tyrosine Kinase 3 (FLT3) Inhibitors to Overcome Clinical Mutations.

Xuan Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.